Key Sessions
Dr. Maureen Merrifield
Regulatory pathway consideration for the licensure of Exosome Therapeutics
Rion Inc.
keyboard_arrow_right
Search & Filter keyboard_arrow_right
keyboard_arrow_left Hide
Main Conference Day 1 (4/11/25) - Amsterdam CET
keyboard_arrow_leftSearch & Filter
search
Streams
Formats
Main Conference Day 1 (4/11/25) - Amsterdam CET
search
Streams
Formats
08:30 - 09:00
Registration & Coffee
09:00 - 09:10
Chair's Opening Remarks
Showing 1 of 1 Streams
Taming the Tiny Giants: Scaling Exosome Production & Purification
09:10 - 09:40
Scaling up production of extracellular vesicles – next step towards clinical therapies against Parkinson‘s disease
- Augustas Pivoriunas - Co-Founder & CSO, Exosomica
09:40 - 10:10
Purity at Scale: Optimizing Exosome DSP
- Patririca Pereira Müller Aguilar - Researcher – Institute of Bioprocess Science and Engineering, BOKU
10:10 - 10:40
Unlocking Scalable Purity: Next-Generation Technologies for Exosome Isolation
Spotlight Presentation – Calling all Technology Thought Leaders!
Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.
Contact us today to learn more: Partners@informaconnectls.com
10:40 - 11:20
Morning Networking Break
Showing 1 of 1 Streams
Harnessing Nature's Nanoparticles: Exosomes in Regeneration & Therapy
11:20 - 11:50
Reversible Immortalization Facilitates the Large-Scale Production of IL10-Enriched Exosomes for Osteoarthritis Therapy
- Weiming Lai - Dr.Med Candidate - nstitut für Anatomie und Zellbiologie, Heidelberg University
11:50 - 12:20
Unlocking the Regenerative Power of Natural Exosomes
- Tali Kizhner - RD Director, NurExone Biologic
12:20 - 12:50
The Unusual Suspects: Exploring Diverse Exosome Sources
- Spencer Marsh - Chief Scientific Officer, Tiny Cargo Company
12:50 - 13:50
Networking Lunch in Exhibit Hall
Showing 1 of 1 Streams
Defining the Dose & Ensuring Quality
13:50 - 14:40
PANEL DISCUSSION: Charting the Course for Standardization: Agreeing on Exosome Quality Metrics
- Key parameters for release criteria and quality control.
- The role of advanced characterization (e.g., single vesicle analysis) in ensuring consistency.
- Establishing robust assays for EV products
- Pathways towards community consensus on standardized methods.
- How standardisation can facilitate regulatory approval & industry evolution
14:40 - 15:10
Deep Dive Analytics: Characterizing Therapeutic Exosomes for Optimal Efficacy
Spotlight Presentation – Calling all Technology Thought Leaders!
Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.
Contact us today to learn more: Partners@informaconnectls.com
15:10 - 15:50
Afternoon Networking Break
Showing 1 of 1 Streams
Navigating the Path to Patients: Regulatory Hurdles & Early Learnings
15:50 - 16:20
Challenges in Clinical Translation for MSC Evs
- Bernd Giebel - Founder & CTO, Exosla Therapeutics
16:20 - 16:50
Regulatory pathway consideration for the licensure of Exosome Therapeutics
- Rion background PEP exosome product
- Chemistry manufacturing and control of exosomes
- Pre-clinical regulatory strategy for exosomes
- Clinical trial progression of exosomes
- Interacting with regulatory bodies to progress the exosome field
- Dr. Maureen Merrifield - Chief Regulatory Officer, Rion Inc.
16:50 - 17:00
Chair's Closing Remarks
17:00 - 18:00
Drinks & Networking Reception
Get the Latest Event Updates
Sign up to get the latest event updates and information.
Filter
Streams
Formats